Stock Price
8.85
Daily Change
-0.12 -1.29%
Monthly
-10.33%
Yearly
121.22%
Q3 Forecast
8.90

DBV Technologies reported $-41758000 in Pre-Tax Profit for its fiscal quarter ending in June of 2025.




Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 40.21M 12.43M Jun/2025
Alnylam Pharmaceuticals USD -35358000 6.24M Jun/2025
Amarin USD -13630000 197K Mar/2025
BioMarin Pharmaceutical USD 297.87M 59.78M Jun/2025
DBV Technologies USD -41758000 18.75M Jun/2025
Halozyme Therapeutics USD 204.94M 61.11M Jun/2025
Incyte USD 558.01M 323.82M Jun/2025
Insmed USD -320443000 64.77M Jun/2025
Ionis Pharmaceuticals USD 124M 271M Jun/2025
Neurocrine Biosciences USD 159.5M 144.8M Jun/2025
PTC Therapeutics USD -71052000 1B Jun/2025
Sarepta Therapeutics USD 153.64M 537.16M Jun/2025
Ultragenyx Pharmaceutical USD -114004000 35.77M Jun/2025
United Therapeutics USD 408.4M 15.1M Jun/2025